Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that presents antipsychotic, anxiolytic, anti-inflammatory and neuroprotective effects. In Parkinson’s disease patients, CBD is able to attenuate the psychotic symptoms induced by L-DOPA and to improve quality of life. Repeated...
Main Authors: | Fernanda Fiel Peres, Raquel Levin, Mayra Akimi Suiama, Mariana Cepollaro Diana, Douglas Albuquerque Gouvêa, Valéria Almeida, Camila Maurício Santos, Lisandro Lungato, Antonio Waldo Zuardi, Jaime Eduardo Hallak, José Alexandre Crippa, Vânia D'Almeida, Regina H Silva, Vanessa Costhek Abilio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00343/full |
Similar Items
-
Reserpine
by: 982 SIRIM -
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
by: Fernanda Fiel Peres, et al.
Published: (2016-09-01) -
Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
by: Cássio Morais Loss, et al.
Published: (2021-02-01) -
Therapeutic potential of Reserpine in metabolic syndrome
by: Udaya Pratap Singh, et al.
Published: (2023-04-01) -
An investigation on the relationship between risk factors and severity of tardive dyskinesia
by: Y Kalafi, et al.
Published: (1993-12-01)